Primary Job Title CEO Primary Organization PhaseBio Pharmaceuticals
Gender Male
LinkedIn View on LinkedIn
Chris has more than 20 years of experience in the development of biopharmaceuticals, involving more than 20 INDs, four NDAs and three product approvals.
Most recently, he was the founder, president and chief scientific officer of BioRexis Pharmaceutical which was acquired by Pfizer in 2007.
In addition to being the founder and president of
Principia Pharmaceuticals, Chris held positions at Human Genome Sciences, Rhône Poulenc Rorer, and Biogen.
A serial entrepreneur, successful fund raiser, and prolific inventor, his success in developing and implementing business development strategies has resulted in the completion of two acquisitions since 2001, generating significant returns to investors.
